Granahan Investment Management, LLC Aerie Pharmaceuticals Inc Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $4.36 Million - $8.07 Million	-881,546 Reduced 55.48%	707,398 $5.31 Million
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $1.97 Million - $3.43 Million	350,061 Added 28.26%	1,588,944 $14.5 Million
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $1.09 Million - $2.07 Million	-155,387 Reduced 11.14%	1,238,883 $8.7 Million
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $71,304 - $104,752	6,299 Added 0.45%	1,394,270 $15.9 Million
Q2 2021 Aug 16, 2021	BUY	$15.16 - $18.97 $3.47 Million - $4.34 Million	228,662 Added 19.72%	1,387,971 $22.2 Million
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $10.8 Million - $17.3 Million	825,546 Added 247.34%	1,159,309 $20.7 Million
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $2.12 Million - $3.37 Million	232,514 Added 229.65%	333,763 $4.51 Million
Q3 2020 Nov 12, 2020	SELL	$10.46 - $14.46 $672,002 - $928,982	-64,245 Reduced 38.82%	101,249 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $566,592 - $761,594	47,216 Added 39.92%	165,494 $2.44 Million
Q1 2020 May 12, 2020	SELL	$11.84 - $25.52 $1.52 Million - $3.27 Million	-128,301 Reduced 52.03%	118,278 $1.6 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $112,752 - $159,711	-6,363 Reduced 2.52%	246,579 $5.96 Million
Q3 2019 Nov 15, 2019	BUY	$18.41 - $28.0 $3.72 Million - $5.66 Million	202,257 Added 399.05%	252,942 $4.86 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $463,780 - $771,793	16,009 Added 46.17%	50,685 $1.5 Million
Q1 2019 May 14, 2019	SELL	$36.32 - $49.25 $826,171 - $1.12 Million	-22,747 Reduced 39.61%	34,676 $1.65 Million
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $1.89 Million - $3.45 Million	57,423 New	57,423 $2.07 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account